Email Updates
Congressional Testimony
Drug Shortages: FDA's Ability to Respond Should Be Strengthened.
January 4, 2012
Testimony before the Committee on Health, Education, Labor, and Pensions, US Senate. US Government Accountability Office. GAO-12-315T (December 15, 2011)
View more articles from the same authors.
This testimony details the US Food and Drug Administration (FDA) response to drug shortage trends and advocates for the agency to have more leverage with manufacturers to address burgeoning shortages.
